Gujarat Kidney IPO Shows Strong Response, Subscribed 5.21x on Day 3

Gujarat Kidney and Super Speciality Limited's initial public offering (IPO) has demonstrated strong investor interest through its third day of subscription. The stock price band is set at ₹108-114 per share. The ₹250.80 crore IPO reached 5.21 times by 5:04:34 PM on day three. 

Gujarat Kidney IPO retail segment leads with exceptional 19.03 times subscription. Non-institutional investors demonstrate strong participation at 5.73 times. Qualified institutional buyers display moderate interest at 1.06 times. Anchor investors show complete participation at 1.00 times.

Gujarat Kidney IPO subscription reached strong 5.21 times on day three. It was led by Retail Investors (19.03x), Non-Institutional Investors (5.73x), and Qualified Institutional Buyers Ex-Anchor (1.06x). Total applications reached 2,59,766.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Subscription Status of Gujarat Kidney IPO:

Here are the subscription details for Gujarat Kidney IPO as of Day 3 (December 24, 2025, 5:04:34 PM):

Key Highlights - Day 3:

• Overall subscription reached strong 5.21 times, showing substantial improvement from day two's 2.72 times
• Retail investors displaying exceptional confidence at 19.03 times, building dramatically from day two's 10.70 times, indicating very strong retail demand for this multispeciality healthcare provider
• Non-institutional investors showing strong performance at 5.73 times, building substantially from day two's 2.97 times, indicating strong HNI appetite
• Qualified institutional buyers (ex-anchor) displaying moderate performance at 1.06 times, improving substantially from day two's 0.34 times, indicating improved institutional interest
• Cumulative bid amount reached ₹786.15 crores, significantly exceeding the issue size of ₹250.80 crores by over 3.1 times
• Anchor investors fully subscribed their allocation of ₹100.01 crores on December 19, 2025

Gujarat Kidney IPO - Day 2 Subscription at 2.72 Times

Key Highlights - Day 1:

• Overall subscription reached moderate 2.72 times, showing substantial improvement from day one's 1.54 times
• Retail investors displaying exceptional confidence at 10.70 times, building dramatically from day one's 5.07 times
• Non-institutional investors showing moderate performance at 2.97 times, building substantially from day one's 1.98 times
• Qualified institutional buyers maintaining weak participation at 0.34 times, unchanged from day one

Gujarat Kidney IPO - Day 1 Subscription at 1.54 Times

Key Highlights - Day 1:

• Overall subscription reached moderate 1.54 times, showing healthy initial investor interest
• Retail investors displaying strong confidence at 5.07 times, indicating robust retail appetite
• Non-institutional investors showing moderate performance at 1.98 times, indicating measured HNI interest
• Qualified institutional buyers showing weak participation at 0.34 times, indicating subdued institutional interest
   

About Gujarat Kidney and Super Speciality Limited

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds. The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand).